Immunohistochemistry Troubleshooting
Immunohistochemistry is a complex experiment with multiple parameters that need to be considered and optimized. The following troubleshooting guides are intended to explain the causes and possible solutions for common problems in immunohistochemistry/immunofluorescence (IHC/IF) staining.

No Staining
| Possible Problems | Recommended Solution(s) |
| Inadequate or excessive tissue fixation | Try increasing the fixation time or try a different fixative. Reduce the duration of the immersion or post-fixation steps. If immersion-fixation cannot be avoided (e.g. collection of postmortem tissues or biopsies in pathology lab), antigens may be unmasked by treatment with antigen retrieval reagents. |
| Epitope altered during fixation or embedding procedure | Try different antigen retrieval methods to restore immunoreactivity. Embed tissue at 58°C or below. |
| Insufficient deparaffinization | Extend the deparaffinization time and replace with fresh xylene. |
| Lack of antigen or insufficient | Run a positive control or use an amplification step to maximize the signal. |
| Antigen retrieval was ineffective | Increase the time of treatment or change the treatment solution. |
| Not enough primary antibody | Increase the concentration of primary or secondary antibodies. Incubate for longer periods of time (e.g. overnight) at 4°C. |
| Incompatible secondary and primary antibodies | Use a secondary antibody that was raised against the species in which the primary was raised (e.g. primary is raised in rabbit, use anti-rabbit secondary). |
| Antibodies do not work due to improper storage | Follow storage instructions on the datasheet. In general, aliquot antibodies into smaller volumes sufficient to make a working solution for a single experiment. Store aliquots in a freezer (-20 to -70°C) and avoid repeated freeze-thaw cycles. |
Inappropriate Staining
| Possible Problems | Recommended Solution(s) |
| Fixation method is inappropriate for the antigen | Try a different fixative or increase the fixation time. |
| Antigen retrieval may be inappropriate for this antigen or tissue | Try different antigen retrieval conditions. |
| Electrostatic charge of the antigen has been altered | Try adjusting the pH or cation concentration of the antibody diluent. |
| Delay in fixation caused diffusion of the antigen | Fix tissue promptly. Try a cross-linking fixative rather than organic (alcohol) fixative. |
High Background
| Possible Problems | Recommended Solution(s) |
| High concentration of primary and/or secondary antibodies | Titer antibody to determine optimal concentration needed to promote a specific reaction of the primary and the secondary antibodies. |
| Non-specific binding of primary and/or secondary reagents to tissues | Use blocking step just prior to primary antibody incubation (we recommend blocking with 10% normal serum for 1 h for sections or with 1-5% BSA for 30 min for cells). |
| Non-specific binding of secondary antibody | Run a secondary control without primary antibody. |
| Tissue dried out | Avoid letting the tissue dry during the staining procedure. |
| Active endogenous peroxidases | Use enzyme inhibitors (e.g. Levamisol (2 mM) for alkaline phosphatase or H2O2 (0.3-3% v/v) for peroxidase). |
Related Sections
Cell Services
Histology Services
For research use only. Not for any other purpose.
Resources
- FAQ
- Protocol
- Cell Culture Guide
- Technical Bulletins
-
Explore & Learn
-
Cell Biology
- How to Handle Mycoplasma in Cell Culture?
- How to Isolate PBMCs from Whole Blood?
- CHO Cell Line Development
- Troubleshooting Cell Culture Contamination: A Comprehensive Guide
- Contamination of Cell Cultures & Treatment
- Generation and Applications of Neural Stem Cells
- Stem Cell Markers
- Comparison of the MSCs from Different Sources
- Quantification of Cytokines
- Organoid Differentiation from Induced Pluripotent Stem Cells
- T Cell Activation and Expansion
- How to Isolate and Analyze Tumor-Infiltrating Leukocytes?
- Mesenchymal Stem Cells: A Comprehensive Exploration
- What are the Differences Between M1 and M2 Macrophages?
- What Cell Lines Are Commonly Used in Biopharmaceutical Production?
- Tips For Cell Cryopreservation
- Cryopreservation of Cells Step by Step
- What are PBMCs?
- STR Profiling—The ID Card of Cell Line
- Comparison of Several Techniques for the Detection of Apoptotic Cells
- Enrichment, Isolation and Characterization of Circulating Tumor Cells (CTCs)
- Strategies for Enrichment of Circulating Tumor Cells (CTCs)
- How to Assess the Migratory and Invasive Capacity of Cells?
- How to Decide Between 2D and 3D Cell Cultures?
- Isolation, Expansion, and Analysis of Natural Killer Cells
- Neural Differentiation from Induced Pluripotent Stem Cells
- How to Eliminate Mycoplasma From Cell Cultures?
- Monocytes vs. Macrophages
- How to Detect and Remove Endotoxins in Biologics?
- Comparison of Different Methods to Measure Cell Viability
- What Are Myeloid Cell Markers?
- How to Start Your Culture: Thawing Frozen Cells
- Biomarkers and Signaling Pathways in Tumor Stem Cells
- Techniques for Cell Separation
- Circulating Tumor Cells as Cancer Biomarkers in the Clinic
- CFU Assay for Hematopoietic Cell
- Guidelines for Cell Banking to Ensure the Safety of Biologics
- Cell Cryopreservation Techniques and Practices
- Cell Culture Medium
- T Cell, NK Cell Differentiation from Induced Pluripotent Stem Cells
- Major Problems Caused by the Use of Uncharacterized Cell Lines
- Critical Quality Attributes and Assays for Induced Pluripotent Stem Cells
- Multi-Differentiation of Peripheral Blood Mononuclear Cells
- Human Primary Cells: Definition, Assay, Applications
- What are Mesothelial Cells?
- How to Scale Up Single-Cell Clones?
- Unveiling the Molecular Secrets of Adipogenesis in MSCs
- Tumor Stem Cells: Identification, Isolation and Therapeutic Interventions
- Direct vs. Indirect Cell-Based ELISA
- What Is Cell Proliferation and How to Analyze It?
- IL-12 Family Cytokines and Their Immune Functions
- Spheroid vs. Organoid: Choosing the Right 3D Model for Your Research
- From Collection to Cure: How ACT Works in Cancer Immunotherapy
- Mastering Cell Culture and Cryopreservation: Key Strategies for Optimal Cell Viability and Stability
- Adherent and Suspension Cell Culture
- Understanding Immunogenicity Assays: A Comprehensive Guide
- How to Maximize Efficiency in Cell-Based High-Throughput Screening?
- What are White Blood Cells?
- Immunogenicity Testing: ELISA and MSD Assays
- Role of Cell-Based Assays in Drug Discovery and Development
- Types of Cell Therapy for Cancer
- 3D-Cell Model in Cell-Based Assay
- Immunogenicity Testing: ELISA and MSD Assays
- What Are the Pros and Cons of Adoptive Cell Therapy?
- Eosinophils vs. Basophils vs. Neutrophils
- 3D-Cell Model in Cell-Based Assay
- Cultivated Meat: What to Know?
- Exploring Cell Dynamics: Migration, Invasion, Adhesion, Angiogenesis, and EMT Assays
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- A Complete Guide to Immortalized Cancer Cell Lines in Cancer Research
- Cell Viability, Proliferation and Cytotoxicity Assays
- What Are CAR T Cells?
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- Optimization Strategies of Cell-Based Assays
- Overview of Cell Apoptosis Assays
- Cell-Based High-Throughput Screening Techniques
- Key Techniques in Primary, Immortalized and Stable Cell Line Development
- From Primary to Immortalized: Navigating Key Cell Lines in Biomedical Research
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- Optimization Strategies of Cell-Based Assays
- Cell Immortalization Step by Step
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
-
Histology
- Fluorescent Nuclear Staining Dyes
- Troubleshooting in Fluorescent Staining
- Immunohistochemistry Controls
- Overview of the FFPE Cell Pellet Product Lines
- Guides for Live Cell Imaging Dyes
- Tips for Choosing the Right Protease Inhibitor
- Instructions for Tumour Tissue Collection, Storage and Dissociation
- Mitochondrial Staining
- How to Apply NGS Technologies to FFPE Tissues?
- Stains Used in Histology
- Multiple Animal Tissue Arrays
- Cell and Tissue Fixation
- Immunohistochemistry Troubleshooting
- Overview of Common Tracking Labels for MSCs
- Cell Lysates: Composition, Properties, and Preparation
- Comparison of Membrane Stains vs. Cell Surface Stains
- Microscope Platforms
- How to Choose the Right Antibody for Immunohistochemistry (IHC)
- How to Begin with Multiplex Immunohistochemistry (mIHC)
- Common Immunohistochemistry Stains and Their Role in Cancer Diagnosis
- Serum vs. Plasma
- Comparing IHC, ICC, and IF: Which One Fits Your Research?
- Modern Histological Techniques
- Multiplexing Immunohistochemistry
- What You Must Know About Neuroscience IHC?
- From Specimen to Slide: Core Methods in Histological Practice
- How Immunohistochemistry Makes the Invisible Brain Visible?
- Histological Staining Techniques: From Traditional Chemical Staining to Immunohistochemistry
-
Exosome
- How to Enhancement Exosome Production?
- Classification, Isolation Techniques and Characterization of Exosomes
- Emerging Technologies and Methodologies for Exosome Research
- How to Label Exosomes?
- How to characterize exosomes?
- How to Perform Targeted Modification of Exosomes?
- Techniques for Exosome Quantification
- Exosomes as Emerging Biomarker Tools for Diseases
- How to Apply Exosomes in Clinical?
- How to Efficiently Utilize MSC Exosomes for Disease Treatment?
- Exosome Transfection for Altering Biomolecular Delivery
- Summary of Approaches for Loading Cargo into Exosomes
- What's the Potential of PELN in Disease Treatment?
- How do PELN Deliver Drugs?
- Current Research Status of Milk Exosomes
- Collection of Exosome Samples and Precautions
- How Important are Lipids in Exosome Composition and Biogenesis?
- Common Techniques for Exosome Nucleic Acid Extraction
- What are the Functions of Exosomal Proteins?
- The Role of Exosomes in Cancer
- Exosome Size Measurement
- Exosome Quality Control: How to Do It?
- Applications of MSC-EVs in Immune Regulation and Regeneration
- Unraveling Biogenesis and Composition of Exosomes
- Exosome Antibodies
- Production of Exosomes: Human Cell Lines and Cultivation Modes
-
ISH/FISH
- ISH probe labeling method
- CARD-FISH: Illuminating Microbial Diversity
- Comprehensive Comparison of IHC, CISH, and FISH Techniques
- RNAscope ISH Technology
- Comparative Genomic Hybridization and Its Applications
- What are the Differences between FISH, aCGH, and NGS?
- FISH Tips and Troubleshooting
- Small RNA Detection by ISH Methods
- What Is the Use of FISH in Solid Tumors?
- Mapping of Transgenes by FISH
- Overview of Oligo-FISH Technology
- Differences Between DNA and RNA Probes
- What are Single, Dual, and Multiplex ISH?
- FISH Techniques for Biofilm Detection
- Whole Chromosome Painting Probes for FISH
- Multiple Options for Proving Monoclonality
- Telomere Length Measurement Methods
- Overview of Common FISH Techniques
- Guidelines for the Design of FISH Probes
- Reagents Used in FISH Experiments
- Multiple Approaches to Karyotyping
- In Situ Hybridization Probes
- What Types of Multicolor FISH Probe Sets Are Available?
- How to Use FISH in Hematologic Neoplasms?
- Different Types of FISH Probes for Oncology Research
- ImmunoFISH: Integrates FISH and IL for Dual Detection
- 9 ISH Tips You Can't Ignore
-
Toxicokinetics & Pharmacokinetics
- Pharmacokinetics of Therapeutic Peptides
- Toxicokinetics vs. Pharmacokinetics
- Organoids in Drug Discovery: Revolutionizing Therapeutic Research
- What Are Metabolism-Mediated Drug-Drug Interactions?
- How to Improve Drug Plasma Stability?
- How Is the Cytotoxicity of Drugs Determined?
- How to Improve the Pharmacokinetic Properties of Peptides?
- How to Conduct a Bioavailability Assessment?
- Organ-on-a-Chip Systems for Drug Screening
- Pharmacokinetics Considerations for Antibody Drug Conjugates
- Key Considerations in Toxicokinetic
- Experimental Methods for Identifying Drug-Drug Interactions
- How to Improve Drug Distribution in the Brain
- Effects of Cytochrome P450 Metabolism on Drug Interactions
- Overview of In Vitro Permeability Assays
- Comparison of MDCK-MDR1 and Caco-2 Cell-Based Permeability Assays
- Traditional vs. Novel Drug Delivery Methods
- What factors influence drug distribution?
- How to Design and Synthesize Antibody Drug Conjugates?
- Methods of Parallel Artificial Membrane Permeability Assays
- Key Factors Influencing Brain Distribution of Drugs
- Unraveling the Role of hERG Channels in Drug Safety
- Predictive Modeling of Metabolic Drug Toxicity
- The Rise of In Vitro Testing in Drug Development
- Physical and Chemical Properties of Drugs and Calculations
- What Is the Role of the Blood-Brain Barrier in Drug Delivery?
- Parameters of Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion
- What are the Pharmacokinetic Properties of the Antisense Oligonucleotides?
- What Are Compartment Models in Pharmacokinetics?
- The 8 Costliest Mistakes in Preclinical CYP Phenotyping
- When Should You Introduce ADME Tox Testing in Drug Development?
- 6 Easy Steps to Get Your In Vitro ADME Done
- From Cells to Systems: Modern Approaches to Disease Modeling
- How to Choose the Right In Vitro ADME Assays for Small-Molecule Drugs
- How Genotoxicity Testing Guides Safer Drug Development
- Top 5 Pitfalls in In Vitro ADME Assays and How to Avoid Them
- What Is Genotoxicity in Pharmacology? Mechanisms and Sources
- In Vitro ADME vs In Vivo ADME
- A Complete Guide to CYP Reaction Phenotyping in 2026
- How to Interpret CYP Phenotyping Data
- Reaction Phenotyping vs. Metabolic Stability
- What Are the Best Methods to Test Cardiotoxicity?
- Why Cardiotoxicity Matters in R&D?
-
Disease Models
- What Human Disease Models Are Available for Drug Development?
- Overview of Cardiovascular Disease Models in Drug Discovery
- Summary of Advantages and Limitations of Different Oncology Animal Models
- Animal Models of Neurodegenerative Diseases
- Preclinical Models of Acute Liver Failure
- Disease Models of Diabetes Mellitus
- Why Use PDX Models for Cancer Research?
-
Cell Biology
- Life Science Articles
- Download Center
- Trending Newsletter